Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$3,727,040
+$491,877 QoQ
Shares Held
14,811
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#1,501
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHEETS SMITH WEALTH MANAGEMENT holds $34,544,473 across 9 Drug Manufacturers - General names. ABBV ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,264 | $17,108,670 | |
| 2 | AMGN |
Amgen Inc
|
17,231 | $6,239,689 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,811 | $3,727,040 | |
| 4 | JNJ |
Johnson & Johnson
|
11,131 | $2,826,940 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,343 | $2,742,575 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,247 | $915,585 | |
| 7 | NVS |
Novartis AG
|
2,450 | $383,964 | |
| 8 | PFE |
Pfizer Inc
|
14,609 | $351,784 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,727,040 | 14,811 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $3,235,163 | 14,875 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,386,678 | 14,822 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,460,365 | 14,945 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,773,905 | 14,944 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $3,124,362 | 14,912 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,655,904 | 14,946 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,994,389 | 15,163 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,661,990 | 15,520 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,854,599 | 15,676 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,440,622 | 15,749 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,422,374 | 16,251 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,369,900 | 17,590 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,808,258 | 17,621 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $2,860,981 | 17,703 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $2,383,838 | 17,762 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,255,127 | 14,724 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,101,326 | 19,131 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,669,275 | 19,714 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,119,214 | 19,646 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $2,230,835 | 19,805 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,152,279 | 19,888 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,092,532 | 19,529 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,665,699 | 19,017 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,811,421 | 18,450 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,298,887 | 17,048 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||